The FDA has approved Empaveli for the treatment of adult and pediatric patients aged 12 years and older with C3G or primary ...

Cuts to Medicaid prompted by the One Big Beautiful Bill Act could lead to thousands of excess deaths each year.

The FDA has granted Fast Track designation to SAP-001 for the treatment of hyperuricemia in adult patients with gout who are refractory to conventional therapy.